GLP-1 Hub: Support, Community, and Weight Loss

Send us Fan Mail
Most people treat GLP-1s as a lifelong prescription. Jason Nelson gives clients 90 days on the medication...then takes them off on purpose.

Registered dietitian Ana Reisdorf talks with Jason Nelson, former competitive bodybuilder and founder of Body Image in Williston Park, NY, about using Ozempic, Wegovy, and other GLP-1 medications as the starting line of a longevity plan — not the finish line. He explains how his team decides when clients taper off, the metabolic markers he tracks, and why physical function matters more than the scale after 60 — including one 64-year-old breast cancer survivor who tested at a biological age of 49.

IN THIS EPISODE
- Why GLP-1s like Ozempic and Wegovy work best as a 90–180 day sprint, not a lifelong medication
- Biological age testing explained: epigenetic methylation, pace of aging, and organ system (Symphony) age
- The metabolic markers to fix first: fasting insulin, A1C, triglycerides, blood pressure, and waist circumference
- How to prevent muscle loss after 60 — anabolic resistance, protein needs, and strength training 4–5 days a week
- Balance training and calf circumference: the overlooked predictors of falls and mortality in older adults

ABOUT THE GUEST
Jason Nelson is a former competitive bodybuilder and the founder of Body Image, a personal training studio in Williston Park, NY, where he's spent 19 years helping hundreds of adults over 40 rebuild their metabolism, strength, and energy. He now leads the Human Optimization Project, a longevity-focused coaching program that combines GLP-1 medication support with strength training, metabolic health optimization, and biological age testing.

CONNECT WITH JASON
Website: https://bodyimage.health
Instagram: @jnelson2580

SPONSOR
Tyde Wellness — licensed GLP-1 providers who actually adjust your dose and stick with you long-term
http://tydewellness.com/GLP1Hub — code GLP1HUB50 for $50 off your first month

CHAPTERS
00:00  A number you can finally measure
01:59  Meet Jason Nelson
03:10  Why your 20s playbook stops working
05:55  Fat loss is the entry point, not the destination
07:24  The metabolic markers that matter
08:34  Testing your biological age
12:53  GLP-1 as a 90-day sprint
14:34  From "skinny" to strong at 80
17:22  Balance, muscle, and falls after 60
25:39  64 years old, biologically 49

MORE FROM GLP-1 HUB
📬 Get The Steady State, Ana's weekly newsletter with GLP-1 guidance from a dietitian who's on one: http://join.glp-1hub.com

🎙 Subscribe wherever you listen to podcasts, and if this episode helped, leave a quick review on Apple Podcasts or Spotify - it's the single best way to help more people find the show.

🌐 Shop GLP-1 essentials, meal plans, and recipes: https://shop.glp-1hub.com
📷 Follow on Instagram: @glp1hub
📺 Watch on YouTube: https://www.youtube.com/@GLP-1hub
*Some of the links shared are affiliate links. When you make a purchase, I will receive a small commission at no cost to you. Thank you for supporting the show.
*The content of this show is for informational purposes only and does not constitute medical advice. The goal of this show is to provide various points of view about GLP-1 Medications. The personal and professional opinion of the guests and their content does not necessarily reflect the opinion of Ana Reisdorf or GLP-1 Hub.

Send us Fan Mail
Your health insurance only makes money when you're sick, which is exactly why GLP-1 coverage keeps getting cut, and why one former WebMD exec is building a model to flip the incentive.

Ana Reisdorf, registered dietitian and GLP-1 user, sits down with Jeremy Shane, founder of Life for Health and former WebMD and Medscape executive, to unpack why the value of Ozempic, Wegovy, and Zepbound shows up 10 to 20 years from now — and nobody in the current system gets paid for that. Jeremy lays out a model that would pay GLP-1 users cash for hitting their health goals, let that money grow tax-deferred like a 401(k), and fund it entirely from dollars already being spent on sick care.

IN THIS EPISODE
- Why health insurers argue there's no long-term ROI on GLP-1 medications — and the Medicare data that says they're wrong
- The Life for Health model: getting paid for sustained metabolic results, with the cash growing tax-deferred inside a universal life insurance policy
- Why self-insured employers (who cover 65% of American workers) are the fastest path to real GLP-1 coverage
- What happens to a long-term GLP-1 plan if you change jobs
- Why life insurers are the only players in healthcare who profit from the absence of disease
- How the 1970s split between medicine and healthcare delivery created the chronic disease crisis we're in now

ABOUT THE GUEST
Jeremy is an lifelong entrepreneur and leader of disruptive businesses in energy, consumer health, and education. His mission is to solve chronic disease, using Life for Health, his approach to increase healthspan using life insurance, instead of health insurance. Chronic disease is a long game, involving completely different scientific and medical risks than the short-term, routine and emergency issues for which health insurance was designed. It's a radical but practically doable way to combine the best of value based care, longevity medicine, and an insurance structure that actually pays people and clinicians over time as they succeed in reversing and preventing disease.

CONNECT WITH JEREMY
Order Life for Health: https://amzn.to/48JAIi1
Learn More About Life for Health: https://www.lifeforhealth.com
Substack: https://hardproblems.substack.com/
X: https://x.com/jeremylshane
LinkedIn: https://www.linkedin.com/in/jeremy-shane-ba62301/

SPONSOR
Timeline (Mitopure) — clinically studied Urolithin A that supports mitochondrial renewal and muscle health, which matters most while losing weight on a GLP-1.
http://timeline.com/GLP1HUB — 20% off your order
Cozy Earth — temperature-regulating viscose bamboo sheets, blankets, and loungewear for the sleep quality your GLP-1 journey depends on. 100-night sleep trial, 10-year warranty. http://cozyearth.com — code GLP1HUB for up to 20% off

CHAPTERS
00:00  Nobody Pays You For Being Healthy
01:37  From WebMD To Life For Health
04:18  The Real Value Of GLP-1s Isn't Weight Loss
07:17  Why Insurers Are Wrong About The ROI
09:24  Getting Paid Cash To Hit Your Goals
13:54  Who Would Actually Fund This
16:25  What If You Switch Jobs?
19:10  The Only Company That Profits From Health
22:22  Making It Affordable For Everyone
25:16  Can We Reverse America's Health Crisis?
29:42  How To Bring This To Your Employer

MORE FROM GLP-1 HUB
📬 Get The Steady State, Ana's weekly newsletter with GLP-1 guidance from a dietitian who's on one: http://join.glp-1hub.com

🎙 Subscribe wherever you listen to podcasts, and if this episode helped, leave a quick review on Apple Podcasts or Spotify - it's the single best way to help more people find the show.

🌐 Shop GLP-1 essentials, meal plans, and recipes: https://shop.glp-1hub.com
📷 Follow on Instagram: @glp1hub
📺 Watch on YouTube: https://www.youtube.com/@GLP-1hub
*Some of the links shared are affiliate links. When you make a purchase, I will receive a small commission at no cost to you. Thank you for supporting the show.
*The content of this show is for informational purposes only and does not constitute medical advice. The goal of this show is to provide various points of view about GLP-1 Medications. The personal and professional opinion of the guests and their content does not necessarily reflect the opinion of Ana Reisdorf or GLP-1 Hub.

Send us Fan Mail
Her A1C was perfect. Her kidneys failed anyway, and Dr. Jason Shumard says it's the same blind spot facing anyone losing weight on a GLP-1.

Registered dietitian Ana Reisdorf talks with Dr. Jason Shumard, DC, a functional medicine practitioner who's spent his career working with type 2 diabetics, about what an A1C number can't tell you. They get into the cholesterol ratio that flags insulin resistance years before your glucose moves, why "eating healthy" usually isn't, and his real concern about staying on Ozempic or another GLP-1 long-term without addressing what's driving the disease underneath.

IN THIS EPISODE
- The triglyceride-to-HDL ratio that signals insulin resistance before A1C or fasting glucose ever moves
- Why a "well-controlled" A1C of 6.1 didn't prevent full kidney failure and dialysis
- Whether GLP-1 medications like Ozempic and Wegovy should be cycled instead of taken continuously for years
- What a low C-peptide reveals about your pancreas after long-term injections
- The bariatric surgery parallel that predicts diabetes coming back even after the weight comes off

ABOUT THE GUEST
Dr. Jason Shumard is a Functional Medicine practitioner with over 20 years of experience specializing in Type 2 Diabetes and insulin resistance. He uses a root-cause, lab-based approach to uncover why blood sugar rises, focusing on factors like hormonal imbalances, inflammation, and metabolic dysfunction. Known for simplifying complex science, Dr. Shumard helps people understand their bodies and take control of their health with practical, personalized strategies. His work is deeply personal, inspired by losing his mother to diabetes complications, which fuels his mission to help others prevent and reverse metabolic disease.

CONNECT WITH DR. SHUMARD
Website: https://drshumard.com
Instagram: @drjasonshumarddc
Free webinar "The Top 3 Secrets That Are Preventing You From Reversing Your Diabetes" : https://drshumardsolution.com/replay

SPONSOR
Tyde Wellness — licensed providers who adjust your GLP-1 dosing as your body changes, plus a real care team for plateaus, side effects, and long-term support.
tydewellness.com/GLP1Hub — code GLP1HUB50 for $50 off your first month

CHAPTERS
00:00  The A1C number that lied
01:54  Meet Dr. Jason Shumard
02:56  The mother who declined despite "good" numbers
05:55  Why there's no single root cause
09:14  The lipid ratio that predicts insulin resistance
11:40  "I eat healthy" — and why it usually isn't
15:23  Adrenals, stress, and hidden chemical load
20:47  The foundation you have to fix first
21:54  Where GLP-1s help — and the cycling concern
25:35  Microdosing, bariatric surgery, and the cell trap

MORE FROM GLP-1 HUB
📬 Get The Steady State, Ana's weekly newsletter with GLP-1 guidance from a dietitian who's on one: http://join.glp-1hub.com

🎙 Subscribe wherever you listen to podcasts, and if this episode helped, leave a quick review on Apple Podcasts or Spotify - it's the single best way to help more people find the show.

🌐 Shop GLP-1 essentials, meal plans, and recipes: https://shop.glp-1hub.com
📷 Follow on Instagram: @glp1hub
📺 Watch on YouTube: https://www.youtube.com/@GLP-1hub
*Some of the links shared are affiliate links. When you make a purchase, I will receive a small commission at no cost to you. Thank you for supporting the show.
*The content of this show is for informational purposes only and does not constitute medical advice. The goal of this show is to provide various points of view about GLP-1 Medications. The personal and professional opinion of the guests and their content does not necessarily reflect the opinion of Ana Reisdorf or GLP-1 Hub.

Send us Fan Mail
In Sweden, universal healthcare won't cover GLP-1s for weight loss, and the $500/month price tag still isn't the biggest barrier to getting a prescription.

Registered dietitian Ana Reisdorf talks with Emma Lidell, host of Sweden's first dedicated weight medicine podcast, about what GLP-1 access really looks like outside the US. They compare out-of-pocket costs for Ozempic, Wegovy, and Mounjaro (Zepbound), unpack Sweden's institutionalized Saturday candy culture, and get into why Emma says the best part of a year on GLP-1s has nothing to do with the scale.

IN THIS EPISODE
- Why Sweden's universal healthcare doesn't cover Ozempic, Wegovy, or Mounjaro for weight loss
- What GLP-1s cost out of pocket in Sweden vs. LillyDirect prices in the US
- Sweden's BMI criteria for GLP-1 prescriptions — and why US doctors ignore the same rules
- How "Saturday candy" culture shaped Sweden's relationship with sugar
- Losing 40 pounds in a year and why food noise relief matters more than weight loss

ABOUT THE GUEST
Emma Lidell is the creator and host of The Weight Medicine Podcast, where she explores what it means to live with obesity and how GLP-1 treatment changes that experience. With a background in communication and storytelling, her work is rooted in her own life — after a lifetime of struggling with weight, food noise, and shame, GLP-1 medication shifted something fundamental for her. She now uses her platform to share real stories, reduce stigma, and examine both the emotional and biological sides of weight in an honest, human way.

CONNECT WITH EMMA
Website: https://www.literalcreations.se
Instagram: @theweightmedicinepodcast

SPONSOR
Timeline — Mitopure gummies with clinically studied Urolithin A to support mitochondrial renewal and muscle health
timeline.com/glp1hub for 20% off

Tyde Wellness — GLP-1 care with licensed providers, real dosing adjustments, and long-term support
tydewellness.com/GLP1Hub, code GLP1HUB50 for $50 off your first month

CHAPTERS
00:00  A country built on Saturday candy
01:46  Meet Sweden's weight medicine podcaster
05:47  Why universal healthcare won't pay
08:38  What Swedes pay out of pocket
14:59  Sweden's real diet problem isn't fast food
16:36  40 pounds down, scale matters less
19:20  Rewiring exercise from punishment to pleasure
20:49  Family reactions and her mom's GLP-1 start
27:05  Where Swedish GLP-1 access is headed

MORE FROM GLP-1 HUB
📬 Get The Steady State, Ana's weekly newsletter with GLP-1 guidance from a dietitian who's on one: http://join.glp-1hub.com

🎙 Subscribe wherever you listen to podcasts, and if this episode helped, leave a quick review on Apple Podcasts or Spotify - it's the single best way to help more people find the show.

🌐 Shop GLP-1 essentials, meal plans, and recipes: https://shop.glp-1hub.com
📷 Follow on Instagram: @glp1hub
📺 Watch on YouTube: https://www.youtube.com/@GLP-1hub
*Some of the links shared are affiliate links. When you make a purchase, I will receive a small commission at no cost to you. Thank you for supporting the show.
*The content of this show is for informational purposes only and does not constitute medical advice. The goal of this show is to provide various points of view about GLP-1 Medications. The personal and professional opinion of the guests and their content does not necessarily reflect the opinion of Ana Reisdorf or GLP-1 Hub.

Send us Fan Mail
Bariatric surgery told her she didn't qualify. Three years later, Kelly Mooney has lost more than 90 pounds on a GLP-1 and the pain from a chronic bone disease that once had her fearing a wheelchair is nearly gone.

Ana Reisdorf, registered dietitian, talks with Kelly Mooney, a Portland-based photographer and former PR professional, about becoming her doctor's very first GLP-1 patient after a bariatric surgeon told her she wasn't sick enough to qualify. Kelly walks through the surprise anti-inflammatory relief from Paget's disease that showed up within weeks, why her weight loss timeline looked nothing like what she saw on social media, and how the medication eventually spread to her husband, her parents, and her in-laws.

IN THIS EPISODE
- Why Kelly didn't qualify for bariatric surgery at a size 24
- The unexpected way GLP-1s eased her Paget's disease bone pain within two weeks
- What a realistic GLP-1 timeline looks like (90 pounds over 3 years, not 30 in a month)
- How her husband, 84-year-old mother-in-law, and 82-year-old father all ended up on GLP-1s too
- Managing constipation, losing the enjoyment of food and wine, and shifting from "willpower" to "medical"

ABOUT THE GUEST
Kelly Mooney is a business owner, photographer, and former PR and marketing professional based in Portland, Oregon. She spent 17 years running her own PR firm, earning clients national media coverage on The Today Show, Oprah, The Wall Street Journal, and USA Today, before shifting to run Kelly Mooney Photography, where she captures authentic, personality-driven imagery for individuals, families, and brands. A former athlete, Kelly stayed active for years but struggled to lose weight despite consistent workouts and programs like Weight Watchers and Overeaters Anonymous. In 2022, after being told she didn't qualify for bariatric surgery, her doctor suggested she try one of the newer GLP-1 medications — Kelly became her first patient, bringing in the research herself to help guide the decision. Since then, she's lost more than 90 pounds and seen a dramatic improvement in her Paget's disease of the bone, going from needing a cane to having knee replacement surgery and rediscovering the athlete in her. For Kelly, the journey has been less about weight loss and more about reclaiming her life and building sustainable, long-term habits.

CONNECT WITH KELLY
Website: kellymooneyphotography.com
LinkedIn: https://www.linkedin.com/company/kellymooneyphotography/
Instagram: @kellymooneyphotography

SPONSOR
Tyde Wellness — licensed GLP-1 providers who actually adjust your dose and stay with you long-term
http://tydewellness.com/GLP1Hub — code GLP1HUB50 for $50 off your first month

CHAPTERS
00:00  Cold open: pain relief within weeks
01:43  Meet Kelly and her lifelong weight struggle
07:17  Denied for bariatric surgery
07:45  Becoming her doctor's first GLP-1 patient
11:05  Sponsor: Tyde Wellness
12:31  The surprise anti-inflammatory relief
14:09  The real timeline: 90 pounds over 3 years
20:33  Husband, parents, and in-laws follow suit
23:34  Shame, side effects, and the medical mindset shift
27:46  Tapering doses, travel, and what's next

MORE FROM GLP-1 HUB
📬 Get The Steady State, Ana's weekly newsletter with GLP-1 guidance from a dietitian who's on one: http://join.glp-1hub.com

🎙 Subscribe wherever you listen to podcasts, and if this episode helped, leave a quick review on Apple Podcasts or Spotify - it's the single best way to help more people find the show.

🌐 Shop GLP-1 essentials, meal plans, and recipes: https://shop.glp-1hub.com
📷 Follow on Instagram: @glp1hub
📺 Watch on YouTube: https://www.youtube.com/@GLP-1hub
*Some of the links shared are affiliate links. When you make a purchase, I will receive a small commission at no cost to you. Thank you for supporting the show.
*The content of this show is for informational purposes only and does not constitute medical advice. The goal of this show is to provide various points of view about GLP-1 Medications. The personal and professional opinion of the guests and their content does not necessarily reflect the opinion of Ana Reisdorf or GLP-1 Hub.